Get the Stockscreener App
16.08
2.37%
-0.39
After Hours:
16.08
Certara Inc stock is currently priced at $16.08, with a 24-hour trading volume of 403.87K.
It has seen a -2.37% decreased in the last 24 hours and a -5.13% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $16.23 pivot point. If it approaches the $15.88 support level, significant changes may occur.
Previous Close:
$16.47
Open:
$16.5
24h Volume:
403.87K
Market Cap:
$2.59B
Revenue:
$360.69M
Net Income/Loss:
$-61.40M
P/E Ratio:
134.00
EPS:
0.12
Net Cash Flow:
$60.93M
1W Performance:
-5.41%
1M Performance:
-5.13%
6M Performance:
+10.06%
1Y Performance:
-21.14%
1D Range:
$15.98
$16.63
52W Range:
$11.81
$22.65
Certara Inc Stock (CERT) Company Profile
Name
Certara Inc
Sector
Industry
Phone
609-716-7900
Address
100 Overlook Center, Suite 101, Princeton
Certara Inc Stock (CERT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-04-24 | Initiated | JMP Securities | Mkt Perform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-07-23 | Initiated | UBS | Neutral |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Aug-22-23 | Downgrade | Jefferies | Buy → Hold |
| Aug-10-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Apr-03-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-08-22 | Initiated | Berenberg | Buy |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-01-22 | Initiated | Piper Sandler | Overweight |
| Jan-11-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Jul-23-21 | Initiated | Robert W. Baird | Outperform |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-06-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jan-05-21 | Initiated | BofA Securities | Buy |
| Jan-05-21 | Initiated | Credit Suisse | Neutral |
| Jan-05-21 | Initiated | Jefferies | Hold |
| Jan-05-21 | Initiated | William Blair | Outperform |
View All
Certara Inc Stock (CERT) Latest News
CERT Stock Sees Decline of Approximately -3.46% in Last Five Days – Knox Daily - Knox Daily
Knox Daily
Massachusetts Financial Services Co. MA Increases Position in Certara, Inc. (NASDAQ:CERT) - MarketBeat
MarketBeat
Massachusetts Financial Services Co. MA Increases Position in Certara, Inc. (NASDAQ:CERT) - MarketBeat
MarketBeat
How did Certara Inc (CERT) fare last session? – US Post News - US Post News
US Post News
Certara, Inc. (NASDAQ:CERT) Shares Sold by Amalgamated Bank - Defense World
Defense World
Upward Trajectory: Certara Inc (CERT) Posts a Slidee, Closing at 15.92 – DWinneX - The Dwinnex
The Dwinnex
Certara Inc Stock (CERT) Financials Data
Certara Inc (CERT) Revenue 2024
CERT reported a revenue (TTM) of $360.69 million for the quarter ending March 31, 2024, a +4.73% rise year-over-year.
Certara Inc (CERT) Net Income 2024
CERT net income (TTM) was -$61.40 million for the quarter ending March 31, 2024, a -542.38% decrease year-over-year.
Certara Inc (CERT) Cash Flow 2024
CERT recorded a free cash flow (TTM) of $60.92 million for the quarter ending March 31, 2024, a -23.97% decrease year-over-year.
Certara Inc (CERT) Earnings per Share 2024
CERT earnings per share (TTM) was -$0.39 for the quarter ending March 31, 2024, a -552.44% decline year-over-year.
Certara Inc Stock (CERT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTIONS |
Apr 02 '24 |
Sale |
16.85 |
14,427 |
243,161 |
50,091 |
| Traynor Richard M. | SVP AND GENERAL COUNSEL |
Apr 01 '24 |
Option Exercise |
0.00 |
13,295 |
0 |
178,800 |
| SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTIONS |
Apr 01 '24 |
Option Exercise |
0.00 |
16,498 |
0 |
67,208 |
| SHERMAN NICOLETTE D | CHIEF HUMAN RESOURCES OFFICER |
Apr 01 '24 |
Option Exercise |
0.00 |
8,219 |
0 |
25,684 |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL OFF |
Apr 01 '24 |
Option Exercise |
0.00 |
16,498 |
0 |
152,840 |
| Gallagher John E | CHIEF FINANCIAL OFFICER |
Apr 01 '24 |
Option Exercise |
0.00 |
27,295 |
0 |
22,545 |
| Aspbury Robert | PRESIDENT; SCIENTIFIC SOFTWARE |
Apr 01 '24 |
Option Exercise |
0.00 |
16,498 |
0 |
293,867 |
| Feehery William F | CHIEF EXECUTIVE OFFICER |
Apr 01 '24 |
Option Exercise |
0.00 |
69,799 |
0 |
2,263,269 |
| Traynor Richard M. | SVP AND GENERAL COUNSEL |
Apr 01 '24 |
Sale |
18.00 |
3,000 |
54,000 |
173,524 |
| Traynor Richard M. | SVP AND GENERAL COUNSEL |
Mar 04 '24 |
Sale |
18.28 |
3,000 |
54,840 |
162,368 |
About Certara Inc
Certara Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinincal and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software and technology to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. The company serves biopharmaceutical companies and academic institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, and Australia. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.
1.03%
1.96%
Cap:
|
Volume (24h):